Your basket is currently empty!
BBC Presenter’s Shocking Alzheimer’s Diagnosis Exposes Broken Care System
Reading Time: 5 minutes. In an unfortunate turn of events, Susan Rae, a respected BBC Radio 4 presenter, has been diagnosed with early-onset Alzheimer’s disease. This rare form of Alzheimer’s, which usually affects older individuals, has hit the media world hard. Alzheimer’s is a devastating condition that impacts not only those diagnosed but also their…
Barrier to a Cure: Limited Eligibility for Alzheimer’s Patients
Reading Time: 4 minutes. In a surprising twist, many Alzheimer’s patients are unable to access promising new treatments due to strict eligibility rules. These new treatments, such as lecanemab and aducanumab, use monoclonal antibodies to tackle the amyloid-ß deposits in the brain. However, only a small number of early-stage patients qualify for these clinical trials.…
Alzheimer’s Breakthroughs Fuel Parkinson’s Research Revolution
Reading Time: 5 minutes. Groundbreaking progress in Alzheimer’s research is now leading to a renaissance in Parkinson’s disease studies. This report examines the far-reaching effects these strides have had on the Parkinson’s research sector. It looks into partnerships, clinical trials, funding, disease mechanisms, and improvements in trial design. Over the past decade, Alzheimer’s research has…
Unlocking Potential: Methylene Blue For Enhancing Women’s Brain Health
Reading Time: 12 minutes. Can a simple compound, once used as an antidote for cyanide poisoning and treatment for malaria, unlock the secrets to enhanced brain health in women? Methylene blue, a heterocyclic aromatic chemical compound with a rich history dating back to the late 19th century, may just hold that potential. This article delves…
Safeguarding the Brain: Exploring Methylene Blue’s Neuroprotective Potential
Reading Time: 13 minutes. According to the World Health Organisation, neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease, are predicted to surpass cancer as the second leading cause of death in the next 20 years. This alarming statistic emphasises an urgent need for innovative therapeutic strategies that could slow down or even prevent these…
Alzheimer’s and Home Safety: Preventing Wandering
Reading Time: 7 minutes. Navigating through the fog of Alzheimer’s disease presents numerous challenges, particularly with regard to patient safety in their home environment. This article explores the significant issue of wandering, a common behaviour among individuals afflicted with this condition. It further provides practical preventive measures and strategies to enhance home safety, highlighting also…
Consult Your Healthcare Provider: Ensuring Safe Use of Methylene Blue with Other Medications
Reading Time: 8 minutes. You have probably heard the saying “Better safe than sorry”, and when it comes to your health, this is certainly true. One area where caution is particularly important is when combining medications, especially if you are considering using methylene blue alongside other prescription or over-the-counter drugs. Methylene blue has been used…
Alzheimer’s and Home Safety: Creating a Senior-Friendly Environment
Reading Time: 8 minutes. Approximately 60% of individuals with Alzheimer’s disease will experience wandering and confusion, increasing their vulnerability to accidents at home. This article examines the correlation between Alzheimer’s and home safety, discussing the essentials for a secure environment. It offers practical tips for dealing with challenging behaviours and introduces technology aids that can…
Recent Post
- Cognitive Impairment in Ageing: Recognising and Addressing Memory Loss
- Guarding The Future: Women’s Health And Strategies For Neuroprotection
- Mitochondrial Dysfunction: The Hidden Cause of Chronic Skin Conditions Like Eczema & TSW
- Emotional Support and Brain Health: The Role of Meaningful Relationships
- Decoding The Differences: Gender-Specific Brain Health Factors
